Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Zhongwen Li, Shuaishuai Niu, Baojie Guo, et al.
Cell Proliferation (2020) Vol. 53, Iss. 12
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
Felice D’Agnillo, Kathie‐Anne Walters, Yongli Xiao, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 198
Pulmonary fibrosis secondary to COVID-19: a narrative review
Suzana Érico Tanni, Alexandre Todorovic Fabro, André Luís Pereira de Albuquerque, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 6, pp. 791-803
Closed Access | Times Cited: 134
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 35
Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery
Pedro Silva Couto, Nada Al-Arawe, Igor Salerno Filgueiras, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19
Mohsen Ghiasi, Peyman Kheirandish Zarandi, Abdolreza Dayani, et al.
Regenerative Therapy (2024) Vol. 27, pp. 319-328
Open Access | Times Cited: 6
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?
Yunyun Quan, Li Li, Zhujun Yin, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
Eleonore Fröhlich
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 32
Residual lung damage following ARDS in COVID‐19 ICU survivors
Nicola Compagnone, Diego Palumbo, George Cremona, et al.
Acta Anaesthesiologica Scandinavica (2021) Vol. 66, Iss. 2, pp. 223-231
Open Access | Times Cited: 31
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation
Amirhesam Babajani, Kasra Moeinabadi‐Bidgoli, Farnaz Niknejad, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed
Xiaolan Wu, Shanshan Jin, Chengye Ding, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 21
SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
Desh Deepak Singh, Anshul Sharma, Hae‐Jeung Lee, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Clinical progress in MSC-based therapies for the management of severe COVID-19
Maria Rossello-Gelabert, Ainhoa Gonzalez‐Pujana, Manoli Igartúa, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 25-36
Open Access | Times Cited: 20
Harvest of functional mesenchymal stem cells derived from
Shunshu Deng, Fuwei Zhu, Kai Dai, et al.
PubMed (2023) Vol. 4, Iss. 4, pp. 270-279
Closed Access | Times Cited: 11
Establishing Minimum Criteria for Stem Cells from Human Exfoliated Deciduous Teeth (SHEDs) Cultured in Human Platelet Lysate (hPL)-Contained Media as Cell Therapy Candidates: Characterization and Predictive Analysis of Secretome Effects
Ji‐Young Yoon, Bình Do Quang, Jisun Shin, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 316-316
Open Access
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Birbal Singh, Gorakh Mal, Vinod Verma, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
Joowon Yim, Hee Hyun Lim, Youngjoo Kwon
Archives of Pharmacal Research (2021) Vol. 44, Iss. 5, pp. 499-513
Open Access | Times Cited: 26
Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
Abu Taiub Mohammed Mohiuddin Chowdhury, Aktar Kamal, Kafil Uddin Abbas, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Mesenchymal stem cells: Emerging concepts and recent advances in their roles in organismal homeostasis and therapy
Peisheng Liu, Yongqian An, Ting Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Wenming Lu, Longxiang Yan, Xingkun Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Exosomes, and the potential for exosome‐based interventions against COVID‐19
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
Najmeh Kaffash Farkhad, Hamidreza Reihani, Alireza Sedaghat, et al.
Regenerative Therapy (2021) Vol. 18, pp. 152-160
Open Access | Times Cited: 21
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
Aidan M. Kirkham, Adrian Bailey, Risa Shorr, et al.
Cytotherapy (2022) Vol. 25, Iss. 3, pp. 341-352
Open Access | Times Cited: 15
Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis
Han Zhong, Yang Zhou, Shuya Mei, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top